rs3755397

This is a regulatory region variant variant in the FARP2 gene.

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

eosinophil count

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele G
OR 0.04
p 3.0e-33
N 408,112
Large GWAS
European
Allele G
OR 0.05
p 2.0e-14
N 365,954
Large GWAS
European
Kachuri L et al. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia. American Journal of Human Genetics 108(10):1823-1835 (2021)
Allele G
OR
p 8.0e-17
N 234,763
Large GWAS
European
Allele G
OR 0.05
p 2.0e-15
N 172,275
Large GWAS
European

eosinophil percentage of leukocytes

Allele G
OR 0.04
p 5.0e-29
N 394,642
Large GWAS
European
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele G
OR 0.03
p 9.0e-16
N 408,112
Large GWAS
European
Allele G
OR 0.05
p 6.0e-14
N 172,378
Large GWAS
European

basophil count, eosinophil count

Allele G
OR 0.05
p 2.0e-15
N 171,771
Large GWAS
European

neutrophil percentage of granulocytes

Allele G
OR 0.05
p 7.0e-14
N 170,672
Large GWAS
European

eosinophil percentage of granulocytes

Allele G
OR 0.04
p 3.0e-13
N 170,536
Large GWAS
European

chronic lymphocytic leukemia

Allele G
OR 1.32
p 9.0e-12
N 17,691
Large GWAS
European

lean body mass

Harris BHL et al. New role of fat-free mass in cancer risk linked with genetic predisposition. Scientific Reports 14(1):7270 (2024)
Allele G
OR 0.01
p 8.0e-10
N 337,739
Large GWAS
European

About FARP2

Enables guanyl-nucleotide exchange factor activity. Acts upstream of or within Rac protein signal transduction and neuron remodeling. Located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]

View all FARP2 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…